Global Non-Invasive Cancer Detection Market Growth (Status and Outlook) 2026-2032
The global Non-Invasive Cancer Detection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Non-invasive cancer testing is a technology that detects cancer by analyzing biomarkers in body fluids such as blood, urine, and saliva without surgery or tissue biopsy. Common non-invasive testing methods include liquid biopsy, genetic testing, and imaging technology, which can detect cancer-related DNA, RNA, proteins, or circulating tumor cells (CTCs) to detect cancer early or monitor disease progression. Non-invasive testing is more comfortable for patients and has lower risks, and is particularly suitable for cancer screening, treatment effect evaluation, and recurrence monitoring.
United States market for Non-Invasive Cancer Detection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Non-Invasive Cancer Detection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Non-Invasive Cancer Detection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Non-Invasive Cancer Detection players cover Trublood, Datar Cancer Genetics, Nucleix, miR Scientific, Owlstone Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Non-Invasive Cancer Detection Industry Forecast? looks at past sales and reviews total world Non-Invasive Cancer Detection sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-Invasive Cancer Detection sales for 2026 through 2032. With Non-Invasive Cancer Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Invasive Cancer Detection industry.
This Insight Report provides a comprehensive analysis of the global Non-Invasive Cancer Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Invasive Cancer Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-Invasive Cancer Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Invasive Cancer Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Invasive Cancer Detection.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Invasive Cancer Detection market by product type, application, key players and key regions and countries.
Segmentation by Type:
Non-invasive cancer testing is a technology that detects cancer by analyzing biomarkers in body fluids such as blood, urine, and saliva without surgery or tissue biopsy. Common non-invasive testing methods include liquid biopsy, genetic testing, and imaging technology, which can detect cancer-related DNA, RNA, proteins, or circulating tumor cells (CTCs) to detect cancer early or monitor disease progression. Non-invasive testing is more comfortable for patients and has lower risks, and is particularly suitable for cancer screening, treatment effect evaluation, and recurrence monitoring.
United States market for Non-Invasive Cancer Detection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Non-Invasive Cancer Detection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Non-Invasive Cancer Detection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Non-Invasive Cancer Detection players cover Trublood, Datar Cancer Genetics, Nucleix, miR Scientific, Owlstone Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Non-Invasive Cancer Detection Industry Forecast? looks at past sales and reviews total world Non-Invasive Cancer Detection sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-Invasive Cancer Detection sales for 2026 through 2032. With Non-Invasive Cancer Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Invasive Cancer Detection industry.
This Insight Report provides a comprehensive analysis of the global Non-Invasive Cancer Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Invasive Cancer Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-Invasive Cancer Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Invasive Cancer Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Invasive Cancer Detection.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Invasive Cancer Detection market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Imaging Test
- Nuclear Medicine Test
- Others
- Prostate Cancer
- Bladder Cancer
- Pancreatic Cancer
- Breast Cancer
- Gastric Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Trublood
- Datar Cancer Genetics
- Nucleix
- miR Scientific
- Owlstone Medical
- bioAffinity Technologies
- Nonacus
- Amadix
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Invasive Cancer Detection Market Size (2021-2032)
2.1.2 Non-Invasive Cancer Detection Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-Invasive Cancer Detection by Country/Region (2021, 2025 & 2032)
2.2 Non-Invasive Cancer Detection Segment by Type
2.2.1 Imaging Test
2.2.2 Nuclear Medicine Test
2.2.3 Others
2.2.4 Non-Invasive Cancer Detection Market Size by Type
2.2.4.1 Non-Invasive Cancer Detection Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Non-Invasive Cancer Detection Market Size Market Share by Type (2021-2026)
2.3 Non-Invasive Cancer Detection Segment by Application
2.3.1 Prostate Cancer
2.3.2 Bladder Cancer
2.3.3 Pancreatic Cancer
2.3.4 Breast Cancer
2.3.5 Gastric Cancer
2.3.6 Others
2.3.7 Non-Invasive Cancer Detection Market Size by Application
2.3.7.1 Non-Invasive Cancer Detection Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.7.2 Global Non-Invasive Cancer Detection Market Size Market Share by Application (2021-2026)
3 NON-INVASIVE CANCER DETECTION MARKET SIZE BY PLAYER
3.1 Non-Invasive Cancer Detection Market Size Market Share by Player
3.1.1 Global Non-Invasive Cancer Detection Revenue by Player (2021-2026)
3.1.2 Global Non-Invasive Cancer Detection Revenue Market Share by Player (2021-2026)
3.2 Global Non-Invasive Cancer Detection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE CANCER DETECTION BY REGION
4.1 Non-Invasive Cancer Detection Market Size by Region (2021-2026)
4.2 Global Non-Invasive Cancer Detection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-Invasive Cancer Detection Market Size Growth (2021-2026)
4.4 APAC Non-Invasive Cancer Detection Market Size Growth (2021-2026)
4.5 Europe Non-Invasive Cancer Detection Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-Invasive Cancer Detection Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-Invasive Cancer Detection Market Size by Country (2021-2026)
5.2 Americas Non-Invasive Cancer Detection Market Size by Type (2021-2026)
5.3 Americas Non-Invasive Cancer Detection Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Invasive Cancer Detection Market Size by Region (2021-2026)
6.2 APAC Non-Invasive Cancer Detection Market Size by Type (2021-2026)
6.3 APAC Non-Invasive Cancer Detection Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-Invasive Cancer Detection Market Size by Country (2021-2026)
7.2 Europe Non-Invasive Cancer Detection Market Size by Type (2021-2026)
7.3 Europe Non-Invasive Cancer Detection Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Invasive Cancer Detection by Region (2021-2026)
8.2 Middle East & Africa Non-Invasive Cancer Detection Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-Invasive Cancer Detection Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE CANCER DETECTION MARKET FORECAST
10.1 Global Non-Invasive Cancer Detection Forecast by Region (2027-2032)
10.1.1 Global Non-Invasive Cancer Detection Forecast by Region (2027-2032)
10.1.2 Americas Non-Invasive Cancer Detection Forecast
10.1.3 APAC Non-Invasive Cancer Detection Forecast
10.1.4 Europe Non-Invasive Cancer Detection Forecast
10.1.5 Middle East & Africa Non-Invasive Cancer Detection Forecast
10.2 Americas Non-Invasive Cancer Detection Forecast by Country (2027-2032)
10.2.1 United States Market Non-Invasive Cancer Detection Forecast
10.2.2 Canada Market Non-Invasive Cancer Detection Forecast
10.2.3 Mexico Market Non-Invasive Cancer Detection Forecast
10.2.4 Brazil Market Non-Invasive Cancer Detection Forecast
10.3 APAC Non-Invasive Cancer Detection Forecast by Region (2027-2032)
10.3.1 China Non-Invasive Cancer Detection Market Forecast
10.3.2 Japan Market Non-Invasive Cancer Detection Forecast
10.3.3 Korea Market Non-Invasive Cancer Detection Forecast
10.3.4 Southeast Asia Market Non-Invasive Cancer Detection Forecast
10.3.5 India Market Non-Invasive Cancer Detection Forecast
10.3.6 Australia Market Non-Invasive Cancer Detection Forecast
10.4 Europe Non-Invasive Cancer Detection Forecast by Country (2027-2032)
10.4.1 Germany Market Non-Invasive Cancer Detection Forecast
10.4.2 France Market Non-Invasive Cancer Detection Forecast
10.4.3 UK Market Non-Invasive Cancer Detection Forecast
10.4.4 Italy Market Non-Invasive Cancer Detection Forecast
10.4.5 Russia Market Non-Invasive Cancer Detection Forecast
10.5 Middle East & Africa Non-Invasive Cancer Detection Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-Invasive Cancer Detection Forecast
10.5.2 South Africa Market Non-Invasive Cancer Detection Forecast
10.5.3 Israel Market Non-Invasive Cancer Detection Forecast
10.5.4 Turkey Market Non-Invasive Cancer Detection Forecast
10.6 Global Non-Invasive Cancer Detection Forecast by Type (2027-2032)
10.7 Global Non-Invasive Cancer Detection Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-Invasive Cancer Detection Forecast
11 KEY PLAYERS ANALYSIS
11.1 Trublood
11.1.1 Trublood Company Information
11.1.2 Trublood Non-Invasive Cancer Detection Product Offered
11.1.3 Trublood Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Trublood Main Business Overview
11.1.5 Trublood Latest Developments
11.2 Datar Cancer Genetics
11.2.1 Datar Cancer Genetics Company Information
11.2.2 Datar Cancer Genetics Non-Invasive Cancer Detection Product Offered
11.2.3 Datar Cancer Genetics Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Datar Cancer Genetics Main Business Overview
11.2.5 Datar Cancer Genetics Latest Developments
11.3 Nucleix
11.3.1 Nucleix Company Information
11.3.2 Nucleix Non-Invasive Cancer Detection Product Offered
11.3.3 Nucleix Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Nucleix Main Business Overview
11.3.5 Nucleix Latest Developments
11.4 miR Scientific
11.4.1 miR Scientific Company Information
11.4.2 miR Scientific Non-Invasive Cancer Detection Product Offered
11.4.3 miR Scientific Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 miR Scientific Main Business Overview
11.4.5 miR Scientific Latest Developments
11.5 Owlstone Medical
11.5.1 Owlstone Medical Company Information
11.5.2 Owlstone Medical Non-Invasive Cancer Detection Product Offered
11.5.3 Owlstone Medical Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Owlstone Medical Main Business Overview
11.5.5 Owlstone Medical Latest Developments
11.6 bioAffinity Technologies
11.6.1 bioAffinity Technologies Company Information
11.6.2 bioAffinity Technologies Non-Invasive Cancer Detection Product Offered
11.6.3 bioAffinity Technologies Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 bioAffinity Technologies Main Business Overview
11.6.5 bioAffinity Technologies Latest Developments
11.7 Nonacus
11.7.1 Nonacus Company Information
11.7.2 Nonacus Non-Invasive Cancer Detection Product Offered
11.7.3 Nonacus Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Nonacus Main Business Overview
11.7.5 Nonacus Latest Developments
11.8 Amadix
11.8.1 Amadix Company Information
11.8.2 Amadix Non-Invasive Cancer Detection Product Offered
11.8.3 Amadix Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Amadix Main Business Overview
11.8.5 Amadix Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Invasive Cancer Detection Market Size (2021-2032)
2.1.2 Non-Invasive Cancer Detection Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-Invasive Cancer Detection by Country/Region (2021, 2025 & 2032)
2.2 Non-Invasive Cancer Detection Segment by Type
2.2.1 Imaging Test
2.2.2 Nuclear Medicine Test
2.2.3 Others
2.2.4 Non-Invasive Cancer Detection Market Size by Type
2.2.4.1 Non-Invasive Cancer Detection Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Non-Invasive Cancer Detection Market Size Market Share by Type (2021-2026)
2.3 Non-Invasive Cancer Detection Segment by Application
2.3.1 Prostate Cancer
2.3.2 Bladder Cancer
2.3.3 Pancreatic Cancer
2.3.4 Breast Cancer
2.3.5 Gastric Cancer
2.3.6 Others
2.3.7 Non-Invasive Cancer Detection Market Size by Application
2.3.7.1 Non-Invasive Cancer Detection Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.7.2 Global Non-Invasive Cancer Detection Market Size Market Share by Application (2021-2026)
3 NON-INVASIVE CANCER DETECTION MARKET SIZE BY PLAYER
3.1 Non-Invasive Cancer Detection Market Size Market Share by Player
3.1.1 Global Non-Invasive Cancer Detection Revenue by Player (2021-2026)
3.1.2 Global Non-Invasive Cancer Detection Revenue Market Share by Player (2021-2026)
3.2 Global Non-Invasive Cancer Detection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE CANCER DETECTION BY REGION
4.1 Non-Invasive Cancer Detection Market Size by Region (2021-2026)
4.2 Global Non-Invasive Cancer Detection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-Invasive Cancer Detection Market Size Growth (2021-2026)
4.4 APAC Non-Invasive Cancer Detection Market Size Growth (2021-2026)
4.5 Europe Non-Invasive Cancer Detection Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-Invasive Cancer Detection Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-Invasive Cancer Detection Market Size by Country (2021-2026)
5.2 Americas Non-Invasive Cancer Detection Market Size by Type (2021-2026)
5.3 Americas Non-Invasive Cancer Detection Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Invasive Cancer Detection Market Size by Region (2021-2026)
6.2 APAC Non-Invasive Cancer Detection Market Size by Type (2021-2026)
6.3 APAC Non-Invasive Cancer Detection Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-Invasive Cancer Detection Market Size by Country (2021-2026)
7.2 Europe Non-Invasive Cancer Detection Market Size by Type (2021-2026)
7.3 Europe Non-Invasive Cancer Detection Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Invasive Cancer Detection by Region (2021-2026)
8.2 Middle East & Africa Non-Invasive Cancer Detection Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-Invasive Cancer Detection Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE CANCER DETECTION MARKET FORECAST
10.1 Global Non-Invasive Cancer Detection Forecast by Region (2027-2032)
10.1.1 Global Non-Invasive Cancer Detection Forecast by Region (2027-2032)
10.1.2 Americas Non-Invasive Cancer Detection Forecast
10.1.3 APAC Non-Invasive Cancer Detection Forecast
10.1.4 Europe Non-Invasive Cancer Detection Forecast
10.1.5 Middle East & Africa Non-Invasive Cancer Detection Forecast
10.2 Americas Non-Invasive Cancer Detection Forecast by Country (2027-2032)
10.2.1 United States Market Non-Invasive Cancer Detection Forecast
10.2.2 Canada Market Non-Invasive Cancer Detection Forecast
10.2.3 Mexico Market Non-Invasive Cancer Detection Forecast
10.2.4 Brazil Market Non-Invasive Cancer Detection Forecast
10.3 APAC Non-Invasive Cancer Detection Forecast by Region (2027-2032)
10.3.1 China Non-Invasive Cancer Detection Market Forecast
10.3.2 Japan Market Non-Invasive Cancer Detection Forecast
10.3.3 Korea Market Non-Invasive Cancer Detection Forecast
10.3.4 Southeast Asia Market Non-Invasive Cancer Detection Forecast
10.3.5 India Market Non-Invasive Cancer Detection Forecast
10.3.6 Australia Market Non-Invasive Cancer Detection Forecast
10.4 Europe Non-Invasive Cancer Detection Forecast by Country (2027-2032)
10.4.1 Germany Market Non-Invasive Cancer Detection Forecast
10.4.2 France Market Non-Invasive Cancer Detection Forecast
10.4.3 UK Market Non-Invasive Cancer Detection Forecast
10.4.4 Italy Market Non-Invasive Cancer Detection Forecast
10.4.5 Russia Market Non-Invasive Cancer Detection Forecast
10.5 Middle East & Africa Non-Invasive Cancer Detection Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-Invasive Cancer Detection Forecast
10.5.2 South Africa Market Non-Invasive Cancer Detection Forecast
10.5.3 Israel Market Non-Invasive Cancer Detection Forecast
10.5.4 Turkey Market Non-Invasive Cancer Detection Forecast
10.6 Global Non-Invasive Cancer Detection Forecast by Type (2027-2032)
10.7 Global Non-Invasive Cancer Detection Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-Invasive Cancer Detection Forecast
11 KEY PLAYERS ANALYSIS
11.1 Trublood
11.1.1 Trublood Company Information
11.1.2 Trublood Non-Invasive Cancer Detection Product Offered
11.1.3 Trublood Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Trublood Main Business Overview
11.1.5 Trublood Latest Developments
11.2 Datar Cancer Genetics
11.2.1 Datar Cancer Genetics Company Information
11.2.2 Datar Cancer Genetics Non-Invasive Cancer Detection Product Offered
11.2.3 Datar Cancer Genetics Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Datar Cancer Genetics Main Business Overview
11.2.5 Datar Cancer Genetics Latest Developments
11.3 Nucleix
11.3.1 Nucleix Company Information
11.3.2 Nucleix Non-Invasive Cancer Detection Product Offered
11.3.3 Nucleix Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Nucleix Main Business Overview
11.3.5 Nucleix Latest Developments
11.4 miR Scientific
11.4.1 miR Scientific Company Information
11.4.2 miR Scientific Non-Invasive Cancer Detection Product Offered
11.4.3 miR Scientific Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 miR Scientific Main Business Overview
11.4.5 miR Scientific Latest Developments
11.5 Owlstone Medical
11.5.1 Owlstone Medical Company Information
11.5.2 Owlstone Medical Non-Invasive Cancer Detection Product Offered
11.5.3 Owlstone Medical Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Owlstone Medical Main Business Overview
11.5.5 Owlstone Medical Latest Developments
11.6 bioAffinity Technologies
11.6.1 bioAffinity Technologies Company Information
11.6.2 bioAffinity Technologies Non-Invasive Cancer Detection Product Offered
11.6.3 bioAffinity Technologies Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 bioAffinity Technologies Main Business Overview
11.6.5 bioAffinity Technologies Latest Developments
11.7 Nonacus
11.7.1 Nonacus Company Information
11.7.2 Nonacus Non-Invasive Cancer Detection Product Offered
11.7.3 Nonacus Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Nonacus Main Business Overview
11.7.5 Nonacus Latest Developments
11.8 Amadix
11.8.1 Amadix Company Information
11.8.2 Amadix Non-Invasive Cancer Detection Product Offered
11.8.3 Amadix Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Amadix Main Business Overview
11.8.5 Amadix Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-Invasive Cancer Detection Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-Invasive Cancer Detection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Imaging Test
Table 4. Major Players of Nuclear Medicine Test
Table 5. Major Players of Others
Table 6. Non-Invasive Cancer Detection Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Non-Invasive Cancer Detection Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Non-Invasive Cancer Detection Market Size Market Share by Type (2021-2026)
Table 9. Non-Invasive Cancer Detection Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Non-Invasive Cancer Detection Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Non-Invasive Cancer Detection Market Size Market Share by Application (2021-2026)
Table 12. Global Non-Invasive Cancer Detection Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Non-Invasive Cancer Detection Revenue Market Share by Player (2021-2026)
Table 14. Non-Invasive Cancer Detection Key Players Head office and Products Offered
Table 15. Non-Invasive Cancer Detection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Non-Invasive Cancer Detection Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Non-Invasive Cancer Detection Market Size Market Share by Region (2021-2026)
Table 20. Global Non-Invasive Cancer Detection Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Non-Invasive Cancer Detection Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Non-Invasive Cancer Detection Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Non-Invasive Cancer Detection Market Size Market Share by Country (2021-2026)
Table 24. Americas Non-Invasive Cancer Detection Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Non-Invasive Cancer Detection Market Size Market Share by Type (2021-2026)
Table 26. Americas Non-Invasive Cancer Detection Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Non-Invasive Cancer Detection Market Size Market Share by Application (2021-2026)
Table 28. APAC Non-Invasive Cancer Detection Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Non-Invasive Cancer Detection Market Size Market Share by Region (2021-2026)
Table 30. APAC Non-Invasive Cancer Detection Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Non-Invasive Cancer Detection Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Non-Invasive Cancer Detection Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Non-Invasive Cancer Detection Market Size Market Share by Country (2021-2026)
Table 34. Europe Non-Invasive Cancer Detection Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Non-Invasive Cancer Detection Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Non-Invasive Cancer Detection Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Non-Invasive Cancer Detection Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Non-Invasive Cancer Detection Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Non-Invasive Cancer Detection
Table 40. Key Market Challenges & Risks of Non-Invasive Cancer Detection
Table 41. Key Industry Trends of Non-Invasive Cancer Detection
Table 42. Global Non-Invasive Cancer Detection Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Non-Invasive Cancer Detection Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Non-Invasive Cancer Detection Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Non-Invasive Cancer Detection Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Trublood Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 47. Trublood Non-Invasive Cancer Detection Product Offered
Table 48. Trublood Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Trublood Main Business
Table 50. Trublood Latest Developments
Table 51. Datar Cancer Genetics Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 52. Datar Cancer Genetics Non-Invasive Cancer Detection Product Offered
Table 53. Datar Cancer Genetics Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Datar Cancer Genetics Main Business
Table 55. Datar Cancer Genetics Latest Developments
Table 56. Nucleix Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 57. Nucleix Non-Invasive Cancer Detection Product Offered
Table 58. Nucleix Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Nucleix Main Business
Table 60. Nucleix Latest Developments
Table 61. miR Scientific Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 62. miR Scientific Non-Invasive Cancer Detection Product Offered
Table 63. miR Scientific Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. miR Scientific Main Business
Table 65. miR Scientific Latest Developments
Table 66. Owlstone Medical Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 67. Owlstone Medical Non-Invasive Cancer Detection Product Offered
Table 68. Owlstone Medical Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Owlstone Medical Main Business
Table 70. Owlstone Medical Latest Developments
Table 71. bioAffinity Technologies Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 72. bioAffinity Technologies Non-Invasive Cancer Detection Product Offered
Table 73. bioAffinity Technologies Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. bioAffinity Technologies Main Business
Table 75. bioAffinity Technologies Latest Developments
Table 76. Nonacus Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 77. Nonacus Non-Invasive Cancer Detection Product Offered
Table 78. Nonacus Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Nonacus Main Business
Table 80. Nonacus Latest Developments
Table 81. Amadix Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 82. Amadix Non-Invasive Cancer Detection Product Offered
Table 83. Amadix Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Amadix Main Business
Table 85. Amadix Latest Developments
Table 1. Non-Invasive Cancer Detection Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-Invasive Cancer Detection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Imaging Test
Table 4. Major Players of Nuclear Medicine Test
Table 5. Major Players of Others
Table 6. Non-Invasive Cancer Detection Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Non-Invasive Cancer Detection Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Non-Invasive Cancer Detection Market Size Market Share by Type (2021-2026)
Table 9. Non-Invasive Cancer Detection Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Non-Invasive Cancer Detection Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Non-Invasive Cancer Detection Market Size Market Share by Application (2021-2026)
Table 12. Global Non-Invasive Cancer Detection Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Non-Invasive Cancer Detection Revenue Market Share by Player (2021-2026)
Table 14. Non-Invasive Cancer Detection Key Players Head office and Products Offered
Table 15. Non-Invasive Cancer Detection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Non-Invasive Cancer Detection Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Non-Invasive Cancer Detection Market Size Market Share by Region (2021-2026)
Table 20. Global Non-Invasive Cancer Detection Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Non-Invasive Cancer Detection Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Non-Invasive Cancer Detection Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Non-Invasive Cancer Detection Market Size Market Share by Country (2021-2026)
Table 24. Americas Non-Invasive Cancer Detection Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Non-Invasive Cancer Detection Market Size Market Share by Type (2021-2026)
Table 26. Americas Non-Invasive Cancer Detection Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Non-Invasive Cancer Detection Market Size Market Share by Application (2021-2026)
Table 28. APAC Non-Invasive Cancer Detection Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Non-Invasive Cancer Detection Market Size Market Share by Region (2021-2026)
Table 30. APAC Non-Invasive Cancer Detection Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Non-Invasive Cancer Detection Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Non-Invasive Cancer Detection Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Non-Invasive Cancer Detection Market Size Market Share by Country (2021-2026)
Table 34. Europe Non-Invasive Cancer Detection Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Non-Invasive Cancer Detection Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Non-Invasive Cancer Detection Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Non-Invasive Cancer Detection Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Non-Invasive Cancer Detection Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Non-Invasive Cancer Detection
Table 40. Key Market Challenges & Risks of Non-Invasive Cancer Detection
Table 41. Key Industry Trends of Non-Invasive Cancer Detection
Table 42. Global Non-Invasive Cancer Detection Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Non-Invasive Cancer Detection Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Non-Invasive Cancer Detection Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Non-Invasive Cancer Detection Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Trublood Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 47. Trublood Non-Invasive Cancer Detection Product Offered
Table 48. Trublood Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Trublood Main Business
Table 50. Trublood Latest Developments
Table 51. Datar Cancer Genetics Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 52. Datar Cancer Genetics Non-Invasive Cancer Detection Product Offered
Table 53. Datar Cancer Genetics Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Datar Cancer Genetics Main Business
Table 55. Datar Cancer Genetics Latest Developments
Table 56. Nucleix Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 57. Nucleix Non-Invasive Cancer Detection Product Offered
Table 58. Nucleix Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Nucleix Main Business
Table 60. Nucleix Latest Developments
Table 61. miR Scientific Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 62. miR Scientific Non-Invasive Cancer Detection Product Offered
Table 63. miR Scientific Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. miR Scientific Main Business
Table 65. miR Scientific Latest Developments
Table 66. Owlstone Medical Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 67. Owlstone Medical Non-Invasive Cancer Detection Product Offered
Table 68. Owlstone Medical Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Owlstone Medical Main Business
Table 70. Owlstone Medical Latest Developments
Table 71. bioAffinity Technologies Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 72. bioAffinity Technologies Non-Invasive Cancer Detection Product Offered
Table 73. bioAffinity Technologies Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. bioAffinity Technologies Main Business
Table 75. bioAffinity Technologies Latest Developments
Table 76. Nonacus Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 77. Nonacus Non-Invasive Cancer Detection Product Offered
Table 78. Nonacus Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Nonacus Main Business
Table 80. Nonacus Latest Developments
Table 81. Amadix Details, Company Type, Non-Invasive Cancer Detection Area Served and Its Competitors
Table 82. Amadix Non-Invasive Cancer Detection Product Offered
Table 83. Amadix Non-Invasive Cancer Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Amadix Main Business
Table 85. Amadix Latest Developments
LIST OF FIGURES
Figure 1. Non-Invasive Cancer Detection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Invasive Cancer Detection Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-Invasive Cancer Detection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-Invasive Cancer Detection Sales Market Share by Country/Region (2025)
Figure 8. Non-Invasive Cancer Detection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-Invasive Cancer Detection Market Size Market Share by Type in 2025
Figure 10. Non-Invasive Cancer Detection in Prostate Cancer
Figure 11. Global Non-Invasive Cancer Detection Market: Prostate Cancer (2021-2026) & ($ millions)
Figure 12. Non-Invasive Cancer Detection in Bladder Cancer
Figure 13. Global Non-Invasive Cancer Detection Market: Bladder Cancer (2021-2026) & ($ millions)
Figure 14. Non-Invasive Cancer Detection in Pancreatic Cancer
Figure 15. Global Non-Invasive Cancer Detection Market: Pancreatic Cancer (2021-2026) & ($ millions)
Figure 16. Non-Invasive Cancer Detection in Breast Cancer
Figure 17. Global Non-Invasive Cancer Detection Market: Breast Cancer (2021-2026) & ($ millions)
Figure 18. Non-Invasive Cancer Detection in Gastric Cancer
Figure 19. Global Non-Invasive Cancer Detection Market: Gastric Cancer (2021-2026) & ($ millions)
Figure 20. Non-Invasive Cancer Detection in Others
Figure 21. Global Non-Invasive Cancer Detection Market: Others (2021-2026) & ($ millions)
Figure 22. Global Non-Invasive Cancer Detection Market Size Market Share by Application in 2025
Figure 23. Global Non-Invasive Cancer Detection Revenue Market Share by Player in 2025
Figure 24. Global Non-Invasive Cancer Detection Market Size Market Share by Region (2021-2026)
Figure 25. Americas Non-Invasive Cancer Detection Market Size 2021-2026 ($ millions)
Figure 26. APAC Non-Invasive Cancer Detection Market Size 2021-2026 ($ millions)
Figure 27. Europe Non-Invasive Cancer Detection Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Non-Invasive Cancer Detection Market Size 2021-2026 ($ millions)
Figure 29. Americas Non-Invasive Cancer Detection Value Market Share by Country in 2025
Figure 30. United States Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Non-Invasive Cancer Detection Market Size Market Share by Region in 2025
Figure 35. APAC Non-Invasive Cancer Detection Market Size Market Share by Type (2021-2026)
Figure 36. APAC Non-Invasive Cancer Detection Market Size Market Share by Application (2021-2026)
Figure 37. China Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 41. India Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Non-Invasive Cancer Detection Market Size Market Share by Country in 2025
Figure 44. Europe Non-Invasive Cancer Detection Market Size Market Share by Type (2021-2026)
Figure 45. Europe Non-Invasive Cancer Detection Market Size Market Share by Application (2021-2026)
Figure 46. Germany Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 47. France Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Non-Invasive Cancer Detection Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Non-Invasive Cancer Detection Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Non-Invasive Cancer Detection Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 60. APAC Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 61. Europe Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 63. United States Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 64. Canada Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 65. Mexico Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 66. Brazil Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 67. China Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 68. Japan Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 69. Korea Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 71. India Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 72. Australia Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 73. Germany Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 74. France Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 75. UK Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 76. Italy Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 77. Russia Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 78. Egypt Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 79. South Africa Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 80. Israel Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 81. Turkey Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 82. Global Non-Invasive Cancer Detection Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Non-Invasive Cancer Detection Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 1. Non-Invasive Cancer Detection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Invasive Cancer Detection Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-Invasive Cancer Detection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-Invasive Cancer Detection Sales Market Share by Country/Region (2025)
Figure 8. Non-Invasive Cancer Detection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-Invasive Cancer Detection Market Size Market Share by Type in 2025
Figure 10. Non-Invasive Cancer Detection in Prostate Cancer
Figure 11. Global Non-Invasive Cancer Detection Market: Prostate Cancer (2021-2026) & ($ millions)
Figure 12. Non-Invasive Cancer Detection in Bladder Cancer
Figure 13. Global Non-Invasive Cancer Detection Market: Bladder Cancer (2021-2026) & ($ millions)
Figure 14. Non-Invasive Cancer Detection in Pancreatic Cancer
Figure 15. Global Non-Invasive Cancer Detection Market: Pancreatic Cancer (2021-2026) & ($ millions)
Figure 16. Non-Invasive Cancer Detection in Breast Cancer
Figure 17. Global Non-Invasive Cancer Detection Market: Breast Cancer (2021-2026) & ($ millions)
Figure 18. Non-Invasive Cancer Detection in Gastric Cancer
Figure 19. Global Non-Invasive Cancer Detection Market: Gastric Cancer (2021-2026) & ($ millions)
Figure 20. Non-Invasive Cancer Detection in Others
Figure 21. Global Non-Invasive Cancer Detection Market: Others (2021-2026) & ($ millions)
Figure 22. Global Non-Invasive Cancer Detection Market Size Market Share by Application in 2025
Figure 23. Global Non-Invasive Cancer Detection Revenue Market Share by Player in 2025
Figure 24. Global Non-Invasive Cancer Detection Market Size Market Share by Region (2021-2026)
Figure 25. Americas Non-Invasive Cancer Detection Market Size 2021-2026 ($ millions)
Figure 26. APAC Non-Invasive Cancer Detection Market Size 2021-2026 ($ millions)
Figure 27. Europe Non-Invasive Cancer Detection Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Non-Invasive Cancer Detection Market Size 2021-2026 ($ millions)
Figure 29. Americas Non-Invasive Cancer Detection Value Market Share by Country in 2025
Figure 30. United States Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Non-Invasive Cancer Detection Market Size Market Share by Region in 2025
Figure 35. APAC Non-Invasive Cancer Detection Market Size Market Share by Type (2021-2026)
Figure 36. APAC Non-Invasive Cancer Detection Market Size Market Share by Application (2021-2026)
Figure 37. China Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 41. India Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Non-Invasive Cancer Detection Market Size Market Share by Country in 2025
Figure 44. Europe Non-Invasive Cancer Detection Market Size Market Share by Type (2021-2026)
Figure 45. Europe Non-Invasive Cancer Detection Market Size Market Share by Application (2021-2026)
Figure 46. Germany Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 47. France Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Non-Invasive Cancer Detection Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Non-Invasive Cancer Detection Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Non-Invasive Cancer Detection Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Non-Invasive Cancer Detection Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 60. APAC Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 61. Europe Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 63. United States Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 64. Canada Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 65. Mexico Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 66. Brazil Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 67. China Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 68. Japan Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 69. Korea Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 71. India Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 72. Australia Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 73. Germany Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 74. France Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 75. UK Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 76. Italy Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 77. Russia Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 78. Egypt Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 79. South Africa Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 80. Israel Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 81. Turkey Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
Figure 82. Global Non-Invasive Cancer Detection Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Non-Invasive Cancer Detection Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Non-Invasive Cancer Detection Market Size 2027-2032 ($ millions)
